Navigation Links
Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease

arly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Genzyme(R) and Renagel(R) are registered trademarks and Renvela(TM) is a trademark of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at www.genzyme.com and by calling Genzyme's investor information line at 1-800- 905-4369 within the United States or 1-703-797-1866 outside the United States.

     Media Contact:        Investor Contact:

     Bo Piela              Sally Curley

     (617) 768-6579        (617) 768-6140

CONTACT: Media, Bo Piela, +1-617-768-6579, or Investors, Sally Curley,+1-617-768-6140, both of Genzyme Corp.

Web site: http://www.genzyme.com/http://www.renagel.com/

Company News On-Call: http://www.prnewswire.com/comp/104284.html /

Ticker Symbol: (NASDAQ-NMS:GENZ)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
5. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
(Date:8/28/2015)... Ill. , Aug. 28, 2015 ... Companies, Inc. (Nasdaq: PDCO ), is now ... previously announced acquisition of Patterson Medical by Madison ... will retain its name for a transition period ... of rehabilitation and sports medicine products.  With the ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Bevacizumab Market 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3
... 2011 Encision Inc. (ECIA:PK), a medical device company ... standard of care in minimally-invasive surgery, announced today that ... of certain electrode tips used in its AEM® surgical ... to breaking off as a consequence of aggressive cleaning ...
... MONTGOMERYVILLE, Pa., Oct. 17, 2011 For the 7.5 ... more than just shorter days, less access to sunlight ... symptoms. With XTRAC® Excimer Laser ( www.XTRACLaser.com ) treatments, psoriasis ... Although every season provides its own unique set of ...
Cached Medicine Technology:Encision Announces Voluntary Recall of Certain Electrode Product 2XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers' Fall Flare-Ups 2XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers' Fall Flare-Ups 3XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers' Fall Flare-Ups 4
(Date:8/31/2015)... Boston, MA (PRWEB) , ... August 31, 2015 , ... ... the Dietary Guidelines advice to "make at least half your grains whole,” with the ... The Boston-based non-profit Oldways Whole Grains Council (WGC) released these findings and ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... efficacy endpoint data collection, cloud analytics and workflow solutions will demonstrate multiple prototypes ... in Lisbon, Portugal, September 22-24, 2015. This is the only European event dedicated ...
(Date:8/31/2015)... ... 31, 2015 , ... On Saturday, July 11, 2015, during the annual New ... City, NYSATA was proud to recognize Dr. Merritt F. Spear as the 2015 recipient ... named after long-time NYSATA member and Ithaca College athletic trainer and educator, is considered ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Intellitec Solutions announced ... by bringing on board their 8th new staff member in 2015. With the potential ... the firm. Intellitec Solutions supports Microsoft Dynamics GP, Dynamics SL, Dynamics CRM and Intacct, ...
(Date:8/31/2015)... ... ... All birth control methods work best if used correctly every time you have ... Moreover, no-scalpel vasectomy has many proven advantages with a lower complication rate over the ... are afraid of complications. , One Stop Medical Center reported a zero failure ...
Breaking Medicine News(10 mins):Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 2Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 3Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3Health News:Intellitec Solutions Achieves Record Pace for New Hiring 2Health News:One Stop Medical Center of Twin Cities Achieves Zero Failure Rate and Infection Rate in No Scalpel Vasectomy 2
... in Honor of National Family Caregiver Month, NAPLES, ... Month, AgingCare.com wants to make a deserving caregiver,s life,a ... $2,000 of,free housecleaning., To enter the contest, family ... sweet moment they,ve shared with their,loved one, some upbeat ...
... MONICA, Calif., Nov. 13 Cord Blood,America, Inc. ... stem,cell preservation company ( http://www.cordblood-america.com ) focused on,bringing ... families nationwide and,internationally, said today that a letter ... on the Company,s website. The letter explains,some of ...
... Comedy Writer, Alan Zweibel, Keynote Speaker, NEW ... tickets,for Turn the Corner Foundation,s, http://www.turnthecorner.org, ... The big event, Unmask a,Cure, will be held ... in,New York City. Celebrities and prominent physicians involved ...
... Hospital, a state-run,psychiatric hospital in the Catawba Valley ... comfort systems to make the buildings,more energy efficient ... hospital anticipates $1 million in savings over five ... associated with the new,heating, ventilating and air conditioning ...
... launch Moxatag(TM), the first and only FDA-approved ... of 2009, GERMANTOWN, Md., Nov. 13 , ... closed a $100 million financing transaction with ... -- MiddleBrook repurchased the Keflex(R) assets for approximately $11.0 ...
... Sports and,Nutritional Supplements developer and manufacturer ... that the company,s primary operating,subsidiary, Interactive Nutrition ... exclusive contract for manufacturing and distribution of ... Sigurdur Arnason and,companies owned by Sigurdur Arnason. ...
Cached Medicine News:Health News:People Caring for Aging Parents Can Win $2,000 of Free Housecleaning 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 3Health News:Turn the Corner Honors Andy Abrahams Wilson, Director of Under Our Skin, for His Dedication in the Fight Against Lyme Disease 2Health News:Turn the Corner Honors Andy Abrahams Wilson, Director of Under Our Skin, for His Dedication in the Fight Against Lyme Disease 3Health News:Virginia Mental Health Hospital Improves Patient Comfort, Receives Award for Energy-Saving Renovations 2Health News:Virginia Mental Health Hospital Improves Patient Comfort, Receives Award for Energy-Saving Renovations 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 8Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 9Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 10Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 11Health News:Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract 2
... broad menu clinical chemistry analyzer designed for ... Care givers can now perform routine multi-chemistry ... minute of hands-on time. Complete panel results ... expensive laboratory analyzers are available in under ...
A simple solution to hand assisted laparoscopic surgery....
... The HandPort Systems non-adhesive ... during Hand-Assisted Laparoscopic Surgrery (HALS) ... touch, grasp, and palpate throughout. ... small as 6 cm, patients ...
... Assisted Laparoscopic Surgery (HALS) device for use ... facilitate the procedure, and for extraction of ... urological and general surgical procedures. It is ... and abdominal access for the surgeon during ...
Medicine Products: